Monitoring Adherence to HIV Antiretroviral Therapy in Routine Clinical Practice: The Past, the Present, and the Future
- 188 Downloads
Adherence to antiretroviral therapy is the strongest predictor of viral suppression, drug resistance, disease progression and death in HIV infected individuals (Bangsberg et al., 2000, 2003; Bangsberg, Hecht et al., 2001; Bangsberg, Perry et al., 2001; de Olalla et al., 2002; Hogg et al., 2002; Paterson et al., 2000). There is, however, no standard approach to adherence assessment in routine clinical practice. This situation is analogous to the general internist managing hypertension with out a blood pressure cuff or the critical care specialist managing a ventilator without measures of oxygenation. Worse yet, providers in routine clinical practice have rarely predicted adherence better than random (Bangsberg, Hecht et al., 2001; Bangsberg, Perry et al., 2001; Gross, Bilker, Friedman, Coyne, and Strom, 2002) which means that we are leaving the most critical determinant of HIV treatment outcomes to chance.
In this edition of AIDS and Behavior, Simoni and colleagues conducted a...
KeywordsHIV adherence resistance electronic medication monitor CASI mediset pill box organizer
- Bangsberg, D.R., Bronstone, A., Chesney, M.A., & Hecht, F.M. (2002). Computer-assisted self-interviewing (CASI) to improve provider assessment of adherence in routine clinical practice. Journal Acquired Immune Deficiency Syndrome, 31(Suppl. 3), S107–S111.Google Scholar
- Gross, R., Zhang, Y., & Grossberg, R. (2005). Medication refill logistics and refill adherence in HIV. Pharmacoepidemiology and Drug Safety.Google Scholar
- Mannheimer, S., Friedland, G., Matts, J., Child, C., & Chesney, M. (2002). The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clinical Infectious Diseases, 34(8), 1115–1121.PubMedCrossRefGoogle Scholar
- Paterson, D.L., Swindells, S., Mohr, J., Brester, M., Vergis, E.N., & Squier, C. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medcine, 133(1), 21–30.Google Scholar
- Ruskin, P., Van der Wende, J., Clark, C., Fenton, J., Deveau, J., & Thapar, R. (2003). Feasibility of using the Med-eMonitor System in the treatment of Schizophrenia: A pilot study. Drug Information Journal, 37(3), 283–291.Google Scholar
- Simoni, J., Kurth, A., Pearson, C., Pantalone, D., Merrill, J., & Frick, P. (2006). Self-reported measures of antiretroviral therapy adherence. Aids and Behavior.Google Scholar
- Weiser, S.D., Guzman, D., Riley, E.D., Clark, R., & Bangsberg, D.R. (2004). Higher rates of viral suppression with nonnucleoside reverse transcriptase inhibitors compared to single protease inhibitors are not explained by better adherence. HIV Clinical Trials, 5(5), 278–287.PubMedCrossRefGoogle Scholar